{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:20:06Z","timestamp":1789572006818,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010805","name":"FORSS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.msard.2023.105126","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T22:45:55Z","timestamp":1699224355000},"page":"105126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-7010","authenticated-orcid":false,"given":"Sara","family":"Hojjati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ernerudh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Vrethem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0120-3734","authenticated-orcid":false,"given":"Johan","family":"Mellerg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Raffetseder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2023.105126_bib0022","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","article-title":"Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases","volume":"127","author":"Akdis","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0032","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","article-title":"Regulation of intracellular levels of NAD: a novel role for CD38","volume":"345","author":"Aksoy","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.msard.2023.105126_bib0011","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2023.105126_bib0023","first-page":"1","article-title":"The immunology of multiple sclerosis","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0004","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.0000000000003946","article-title":"Nrf2, cellular redox regulation, and neurologic implications","volume":"88","author":"Benarroch","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105126_bib0001","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s40265-019-01229-3","article-title":"Dimethyl fumarate: a review in relapsing-remitting MS","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.msard.2023.105126_bib0003","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1089\/ars.2015.6622","article-title":"Pharmacodynamics of dimethyl fumarate are tissue specific and involve NRF2-dependent and-independent mechanisms","volume":"24","author":"Brennan","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.msard.2023.105126_bib0033","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1172\/JCI72151","article-title":"Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate's protective effect in EAE","volume":"124","author":"Chen","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2023.105126_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-019-1420-9","article-title":"Semaphorin4A causes loss of mature oligodendrocytes and demyelination in vivo","volume":"16","author":"Chiou","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105126_bib0034","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0005","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.autrev.2018.07.001","article-title":"Dimethyl fumarate treatment in multiple sclerosis: recent advances in clinical and immunological studies","volume":"17","author":"Diaz","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2023.105126_bib0006","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2205042119","article-title":"High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis","volume":"119","author":"Diebold","year":"2022","journal-title":"Proc. Natl Acad. Sci."},{"key":"10.1016\/j.msard.2023.105126_bib0002","first-page":"1","article-title":"High-efficacy therapies for treatment-na\u00efve individuals with relapsing\u2013remitting multiple sclerosis","author":"Freeman","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2023.105126_bib0025","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s41591-019-0521-4","article-title":"GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis","volume":"25","author":"Galli","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.msard.2023.105126_bib0008","article-title":"Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis","volume":"3","author":"Gross","year":"2016","journal-title":"Neurol. -Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105126_bib0016","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.msard.2023.105126_bib0030","article-title":"Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis","volume":"37","author":"Hansen","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2023.105126_bib0014","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(09)70021-3","article-title":"Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study","volume":"8","author":"Havrdova","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.105126_bib0012","doi-asserted-by":"crossref","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl Acad. Sci."},{"key":"10.1016\/j.msard.2023.105126_bib0045","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.3390\/ijms131013713","article-title":"The role of neurotrophins in multiple sclerosis\u2014Pathological and clinical implications","volume":"13","author":"Kalinowska-Lyszczarz","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2023.105126_bib0043","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41593-022-01097-3","article-title":"Identification of early neurodegenerative pathways in progressive multiple sclerosis","volume":"25","author":"Kaufmann","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.msard.2023.105126_bib0019","unstructured":"Laboratory NRA. verification: weather Forecast Verification Utilities (R package version 1.42). 2015."},{"key":"10.1016\/j.msard.2023.105126_bib0026","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/immu.200310023","article-title":"Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells","volume":"33","author":"Langenkamp","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0044","article-title":"Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination","volume":"29","author":"Linker","year":"2009","journal-title":"Crit. Rev.\u2122 Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0029","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458515608961","article-title":"Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients","volume":"22","author":"Longbrake","year":"2016","journal-title":"Multiple Scler. J."},{"key":"10.1016\/j.msard.2023.105126_bib0042","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.4049\/jimmunol.1102023","article-title":"Elevation of Sema4A Implicates Th Cell Skewing and the Efficacy of IFN-\u03b2 Therapy in Multiple Sclerosis","volume":"188","author":"Nakatsuji","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0041","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.4049\/jimmunol.0903302","article-title":"Roles of Sema4D\u2013Plexin-B1 Interactions in the Central Nervous System for Pathogenesis of Experimental Autoimmune Encephalomyelitis","volume":"184","author":"Okuno","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0024","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.37.7.1097","article-title":"Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system","volume":"37","author":"Panitch","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105126_bib0038","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1098\/rstb.2006.1892","article-title":"Semaphorins in axon regeneration: developmental guidance molecules gone wrong?","volume":"361","author":"Pasterkamp","year":"2006","journal-title":"Philos. Trans. R. Soc. B: Biol. Sci."},{"key":"10.1016\/j.msard.2023.105126_bib0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/joim.13215","article-title":"Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis","volume":"289","author":"Piehl","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.msard.2023.105126_bib0015","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/01.WNL.0000156155.19270.F8","article-title":"Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity","volume":"64","author":"Roxburgh","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.105126_bib0010","first-page":"1324","article-title":"Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment na\u00efve relapsing MS patients","volume":"90","author":"Sejbaek","year":"2019","journal-title":"J. Neurol., Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2023.105126_bib0007","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000076","article-title":"Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate","volume":"2","author":"Spencer","year":"2015","journal-title":"Neurol.-Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.105126_bib0028","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T cells","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.msard.2023.105126_bib0021","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.msard.2023.105126_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577756","article-title":"Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS","volume":"361","author":"Talbot","year":"2021","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2023.105126_bib0018","unstructured":"Team RDC. A language and environment for statistical computing. http:\/\/www.R-project.org 2009."},{"key":"10.1016\/j.msard.2023.105126_bib0020","doi-asserted-by":"crossref","unstructured":"Thiele C. and Hirschfeld G. Cutpointr: improved estimation and validation of optimal cutpoints in R. arXiv preprint arXiv:200209209 2020.","DOI":"10.18637\/jss.v098.i11"},{"key":"10.1016\/j.msard.2023.105126_bib0013","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2023.105126_bib0031","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.msard.2023.105126_bib0036","series-title":"Cellular Migration and Formation of Axons and Dendrites","first-page":"109","article-title":"Chapter 5 - Axon guidance: semaphorin\/neuropilin\/plexin signaling","author":"Verhagen","year":"2020"},{"key":"10.1016\/j.msard.2023.105126_bib0040","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/brain\/awm202","article-title":"Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis?","volume":"130","author":"Williams","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.msard.2023.105126_bib0037","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrd4337","article-title":"Semaphorins and plexins as therapeutic targets","volume":"13","author":"Worzfeld","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.msard.2023.105126_bib0009","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.4049\/jimmunol.1601532","article-title":"Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1\/Th17 and Th2 in multiple sclerosis patients","volume":"198","author":"Wu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2023.105126_bib0017","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823006272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823006272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T01:22:53Z","timestamp":1724894573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823006272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"alternative-id":["S2211034823006272"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.105126","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dimethyl fumarate treatment in relapsing remitting MS changes the inflammatory CSF protein profile by a prominent decrease in T-helper 1 immunity","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.105126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105126"}}